| Literature DB >> 10699450 |
Abstract
Drugs modulating the levels of specific central neurotransmitters may influence both the rate and amount of functional recovery after focal brain injuries such as stroke. Because such drugs may be effective long after brain injury, the "therapeutic window" may be widened beyond the first few hour after stroke and an entirely new avenue for pharmacological intervention may be possible. The impact of drugs affecting norepinephrine and gamma-aminobutyric acid have been among the most extensively studied in the laboratory, and preliminary clinical data suggest similar effects in humans.Entities:
Mesh:
Substances:
Year: 2000 PMID: 10699450 DOI: 10.1016/s0028-3908(99)00249-x
Source DB: PubMed Journal: Neuropharmacology ISSN: 0028-3908 Impact factor: 5.250